{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:38:07Z","timestamp":1758807487385},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Objective.\u2002<\/jats:bold> Impaired renal function is emerging as an independent risk factor for cardiovascular (CV) disease. We analysed the prognostic implications of estimated renal function in patients with angina pectoris.<\/jats:p><jats:p><jats:bold>Design.\u2002<\/jats:bold>  <jats:italic>Post hoc<\/jats:italic> analysis of the Angina Prognosis Study In Stockholm (APSIS). The estimated creatinine clearance (eCrCl) was calculated according to the Cockcroft\u2013Gault formula in 808 patients. Outcomes were compared for subgroups with CrCl \u226590, 60\u201389 and&lt;60\u2003mL\u2003min<jats:sup>\u22121<\/jats:sup>.<\/jats:p><jats:p><jats:bold>Setting.\u2002<\/jats:bold> Hospital\u2010based study with patients referred from primary care and hospital.<\/jats:p><jats:p><jats:bold>Subjects.\u2002<\/jats:bold> A total of 809 patients (248 women) with clinically diagnosed stable angina pectoris.<\/jats:p><jats:p><jats:bold>Intervention.\u2002<\/jats:bold> Double\u2010blind treatment with metoprolol or verapamil.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> One hundred and sixty\u2010four patients (91 women) had an eCrCl below 60\u2003mL\u2003min<jats:sup>\u22121<\/jats:sup>. During a median follow\u2010up of 40\u2003months, 38 patients suffered CV death and 31 patients had a nonfatal myocardial infarction (MI). In a univariate analysis a lower eCrCl was related to a higher risk for CV death or MI amongst men (log rank <jats:italic>P<\/jats:italic>\u2003=\u20030.036). A multivariate Cox analysis showed an independent prognostic importance of eCrCl for CV death (<jats:italic>P<\/jats:italic>\u2003=\u20030.046) and for CV death or MI (<jats:italic>P<\/jats:italic>\u2003=\u20030.042) amongst all patients. When analysed as a continuous variable, a 1\u2003mL min<jats:sup>\u22121<\/jats:sup> decrease in eCrCl was associated with a 1.6% (0.1\u20133.1) increase in the risk for CV death or MI, and a 2.1% (0\u20134.1) increase in the risk for CV death alone.<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold> Renal dysfunction was found to be common in patients with stable angina pectoris and estimated creatinine clearances carried significant independent prognostic information regarding CV death and nonfatal MI.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2006.01728.x","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T13:58:28Z","timestamp":1163685508000},"page":"537-544","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic implications of renal dysfunction in patients with stable angina pectoris"],"prefix":"10.1111","volume":"260","author":[{"given":"T.","family":"ALMQUIST","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"FORSLUND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"REHNQVIST","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"HJEMDAHL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"issue":"2","key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1053\/ajkd.1998.v32.pm9713409","article-title":"Patient mortality and survival. United States Renal Data System","volume":"32","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.13.5_Suppl.I80"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00629.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2989"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041365"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.06.001"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000027560.41358.B3"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.08.016"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103623.63687.21"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.591990"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000123691.46138.E2"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000047041.66447.29"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a014695"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.057703"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80360-0"},{"key":"e_1_2_7_21_2","first-page":"1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative","volume":"39","author":"National Kidney Foundation K\/DOQI Working Group","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518109090505"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200501000-00010"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070549"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01450-4"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.16028.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-1-200401060-00006"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.10.037"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000177"},{"key":"e_1_2_7_32_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","author":"Tonelli M","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00007"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2610"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200306000-00001"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2006.01728.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2006.01728.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:13:00Z","timestamp":1697386380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2006.01728.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1365-2796.2006.01728.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2006.01728.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]}}}